This Bio-Techne Insider Reduced Their Stake By 19%

Simply Wall StJul 1 18:35

KeyBanc Maintains Bio-Techne(TECH.US) With Buy Rating, Maintains Target Price $80

KeyBanc analyst Paul Knight maintains $Bio-Techne(TECH.US)$ with a buy rating, and maintains the target price at $80.According to TipRanks data, the analyst has a success rate of 43.1% and a total ave

Futu NewsJun 24 14:32 · Ratings

Declining Stock and Decent Financials: Is The Market Wrong About Bio-Techne Corporation (NASDAQ:TECH)?

Yahoo FinanceJun 20 22:31

Is There Now An Opportunity In Bio-Techne Corporation (NASDAQ:TECH)?

Simply Wall StJun 13 18:22

BIO-TECHNE TO PRESENT AT UPCOMING INVESTOR CONFERENCES

PR NewswireMay 31 19:00

Express News | Quantum-Si Appoints Former Bio-Techne President and CEO, Chuck Kummeth, to Serve as Independent Chairman of the Board of Directors

BreakingsMay 31 04:05